Rx Patient Assistance Programs Encouraged By Medicare Part D Final Rule

Pharmaceutical manufacturer patient assistance programs can be used to cover out-of-pocket costs for Medicare Part D enrollees, CMS says in its final implementing regulations for the drug benefit